CytImmune Sciences is a clinical-stage biopharmaceutical company developing nano-medicines, anti-cancer agents, and semi-synthetic in vitro immune systems that help produce antibodies.
12
Funding Rounds
$21.1m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide